Bridgeway Capital Management, LLC Annexon, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.14 Billion
- Q2 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 85,000 shares of ANNX stock, worth $597,550. This represents 0.01% of its overall portfolio holdings.
Number of Shares
85,000
Previous 177,500
52.11%
Holding current value
$597,550
Previous $1.27 Million
67.3%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
101MCall Options Held
3.73MPut Options Held
1.3M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$59.4 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$52.1 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$49.2 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$46.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$45.2 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $335M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...